Form 8-K - Current report:
SEC Accession No. 0000950170-25-058687
Filing Date
2025-04-25
Accepted
2025-04-25 16:01:07
Documents
11
Period of Report
2025-04-23
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K alxo-20250423.htm   iXBRL 8-K 48551
  Complete submission text file 0000950170-25-058687.txt   161691

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alxo-20250423.xsd EX-101.SCH 26051
13 EXTRACTED XBRL INSTANCE DOCUMENT alxo-20250423_htm.xml XML 4537
Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

EIN.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39386 | Film No.: 25873630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)